Abiopharma

🔍 Hanson Diana (Executive)

Company: RBB Bancorp (RBB)

Report Date: 2026-08-19

Detailed Transactions and Holdings:

• Acquired 767 shares of Common Stock, No Par Value (Direct)
  Date: 2026-08-19 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,259.00 | transaction_form_type: 4
• Sold 276 shares of Common Stock, No Par Value at $26.4 per share (Direct)
  Date: 2026-08-19 | Code: F | equity_swap_involved: 0 | shares_owned_after: 983.00 | transaction_form_type: 4
• Sold 2,300 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-19 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,533.00 | transaction_form_type: 4 | Footnotes: F4, F2, F1
• Holds 1,255 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-19 | Code: H | shares_owned_after: 1,255.00 | Footnotes: F4, F3, F1

Footnotes:

• F1: There will be no expiration date once restricted stock units vest.
• F2: These remaining restricted stock units vest in two equal annual installments on 08/19/2027 and 08/19/2028.
• F3: These restricted stock units vest in four equal annual installments beginning one year after the 05/13/2026 date of grant.
• F4: Restricted stock units convert into common stock on a one-for-one basis.
• REMARKS: Shares issued for vesting of 8/19/2024 RSU grant and shares disposed in settlement of tax withholding obligations for such RSU vesting.